{"sourcedb":"DevicePMAs@therightstef","sourceid":"N50510_S145","text":"Approval for changes in the antibiotic design specification for the antibiotic trimethoprim/sulfamethoxazole at concentrations of 2/38, 8/152, 16/304, and 32/608 ug/ml to the vitek 2 gram positive ast panel for streptococcus pneumoniae: trimethoprim/sulfamethoxazole.  The device, as modified, will be marketed under the trade name vitek 2 and is indicated for use in vitek 2 gram positive ast panel for streptococcus pneumoniae for the susceptibility testing of streptococcus pneumoniae isolates to trimethoprim/sulfamethoxazole in the range of \u003C= .5/9.5 to \u003E= 16/304 ug/ml.","project":"consensus_PMA_Age_Indications"}